Search Results 1011-1020 of 13928 for Assay

1. Lewy Body Dementia Clinical Trials - Mayo Clinic Research

   Blinded Comparison of Different Alpha-Synuclein Seeding Assays as ... assay measures of aSyn, relative to normal control subjects. Specific Aim 2.

2. FORTIFI-HN01: A Study Of Ficerafusp Alfa (BCA101) Or Placebo In Combination With Pembrolizumab In First-Line PD-L1-pos, R Or M HNSCC - Mayo Clinic

   * PD-L1 CPS ≥1 (by PD-L1 IHC 22C3 pharmDx assay). * Measurable disease based on RECIST 1.1. * Eastern Cooperative Oncology Group (ECOG) performance status ...

3. A Study to Evaluate the Safety and Effectiveness of Anti-CD38 CAR-T in Relapsed or Refractory Multiple Myeloma Patients - Mayo Clinic

   Serum free light chain (FLC) assay; involved FLC level greater than or equal to 10 mg/dL provided the serum FLC ratio is abnormal; OR; Greater than or equal ...

4. A Study to Evaluate Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma - Mayo Clinic

   Undetectable viral load per standard of care assay;; Receiving antiretroviral therapy (ART/HAART) for at least 4 weeks prior to study enrollment, and have ...

5. A Study To Evaluate A Standard-dose And High- Dose Regimen Of Encorafenib + Binimetinib In Patients With BRAFV600-mutant Melanoma Brain Metastasis - Mayo Clinic

   Presence of B-RAF proto-oncogene, V600 mutant (BRAFV600) mutation in tumor tissue previously determined by a local assay at any time prior to Screening or by a ...

6. A Study To Evaluate Firstline Pembrolizumab Alone Or In Combination With Pemetrexed And Carboplatin In Induction/Maintenance Or Postprogression In Treating Patients With Stage IV Non-squamous Non-small Cell Lung Cancer - Mayo Clinic

   The assay must have been performed by a Clinical Laboratory Improvement Act (CLIA) (or equivalent) certified laboratory. Patients must have measurable or ...

7. Early cancer detection test studied at Mayo Clinic is introduced nationally

   She also researches multi-cancer early cancer detection through blood assays and develops novel therapeutics to improve survival in early-stage and metastatic ...

8. Assessment Of Biomarker-Guided CNI Substitution In Kidney Transplantation - Mayo Clinic

   ... assay OR has completed treatment for latent tuberculosis and has a negative chest x-ray. PPD or IGRA testing must occur within 52 weeks prior to ...

9. Phase II Randomized Trial Comparing GA101 and Rituximab in Untreated Low Tumor Burden Indolent Non-Hodgkin's Lymphoma - Mayo Clinic

   ... assays and whole blood B-cell depletion assays. In human lymphoma xenograft models, GA101 exhibits superior antitumor activity, resulting in the induction ...

10. A Study Of The Effectiveness And Safety Of Infliximab For Pediatric Patients With Inflammatory Bowel Disease - Mayo Clinic

    Stool studies must include a stool culture and Clostridium difficile toxin assay. These must have been performed during Screening or the current episode of ...